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Original Article
Angioembolization in itractable epistaxis — a tertiary care experience
Maqbool Ahmed Baloch, Muhammad Sohail Awan, Hassan Nabeel Resident
Department of Surgery, Section Ootlaryngology, Head & Neck Surgery, Aga Khan Univarsity Hospital, Karachi.

Abstract
Objective: To review the role of angioembolization in the control of intractable epistaxis at our institution.
Methods: A retrospective review of the charts of the patients between Jan 2001 to June 2010 at Aga Khan
University Hospital, Karachi was done. All patients who underwent angioembolization for intractable epistaxis
were included in the study. Patients with nasal or nasopharyngeal mass were excluded. Data was analyzed by
using SPSS version 16.
Results: Total numbers of the patients were 16. Fourteen (87.5%) patients were male and 2(12.5%) were female
with mean age 51.2 ± 12.922 years (range 26-71 years). In 11(68.75%) patients there were no associated risk
factors for epistaxis, 3(18.75%) patients had uncontrolled hypertension, 1(6.25%) patient had road traffic
accident and 1(6.25%) patient had bleeding after nasal surgery. All patients were initially treated by anterior and
posterior nasal packing for 48 to 72 hours. Angioembolization successfully controlled epistaxis in all 16 (100%)
patients initially. However, in 2(12.5%) cases embolization had to be repeated; in 1 patient on the same day and
in another patient after one month of initial procedure. The average length of stay after angioembolization was
1.9 ± 0.854 days. No major or permanent complication was observed.
Two (12.5%) patients developed minor complications (1 patient experienced facial pain for 7 days and another
patient developed haematoma at the site of femoral artery).
Conclusion: Angioembolization is a safe and effective treatment option for intractable epistaxis.
Keywords: Angioembolization, Intractable epistaxis, Nasopharyngeal mass, Karachi (JPMA 62: 254; 2012).

Introduction
Epistaxis is defined as acute haemorrhage from
nostril, nasal cavity, or nasopharynx. It is one of the
commonest emergency in ENT practice and often causes
significant anxiety in patients and clinicians. Epistaxis has
been reported to occur in up to 60 percent of the general
population. The condition has a bimodal distribution, with
incidence peaks at ages younger than 10 years and older
than 50 years. Epistaxis appears to occur more often in
males than in females. Although 60% of population
experience epistaxis in their life time but only 6% need any
treatment.1 In majority of the cases, only conservative
measures such as local pressure, vasoconstrictor drugs and
anterior and posterior nasal packing (AP packing) are
needed. Epistaxis not responding to these conservative
measures is known as intractable epistaxis. Such cases can
be treated surgically by ligating internal maxillary, external
carotid or ethmoidal arteries but with the emergence of
interventional radiology these cases can also be managed by
embolizing the bleeding vessels. Sokoloff was the first one
who described the use of embolization in epistaxis.2 Since
then, over the period of time this technique has been
standardized and became a viable option in the management
of intractable epistaxis. However, angioembolization is not
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entirely a risk free procedure and carries potential for some
serious kinds of complications such as facial nerve
paralysis, blindness and soft tissue necrosis.3 At our
institution, embolization is the primary method for
uncontrolled nasal bleeds. Therefore, this paper outlines our
experience of angioembolization for the treatment of
intractable epistaxis.

Methods
It was a retrospective review of cases of epistaxis that
underwent angioembolization between Jan 2001 to June 2010
at this institution. All the patients, embolized for epistaxis,
were included in the study while those who had epistaxis due
to nasal or nasopharyngeal mass were excluded. The chart
review included demographic details, investigations
performed and treatment provided before deciding for
angioembolization. All the data was recorded on a performa
and analysed using SPSS 16.0. Total numbers of the patients
were 16. All patients underwent a complete set of
investigations including history, physical examination and
nasal endoscopy to look for any bleeding point. If the
bleeding did not stop by conservative means, anterior and
posterior nasal packing was done for 48 to 72 hours in these
patients and they were admitted. Nasal bleeds not responding
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to anterior and posterior nasal packing were then embolized
after obtaining the written consent from the patient.
Diagnostic as well as therapeutic angiography was
performed under local anaesthesia in an angiographic
suite by the interventional radiologists. The femoral
approach was used in all cases. Usually 4 Fr catheter was
used and advanced over the guide wire to selectively
cannulate the common carotid, external carotid, internal
maxillary and facial arteries. Non ionic water soluble
contrast was used for the extravasation. Then
microcatheters were utilized to selectively cannulate the
bleeding vessels. Embolization was done with polyvinyle
alcohol (PVA) or with gelfoam. Post embolization run
was given to confirm the cessation of bleeding. Later on
nasal packs were removed. Patients were followed in
ENT clinic after a week. Follow up was also taken on the
phone from all the patients during the study.

Results
Sixteen patients were studied. there were 14 (87.5%)
males and 2 (12.5%) females with a mean age of 51.2 ± 12.92
years (range: 26-71 years).
Eleven (68.75%) patients had idiopathic epistaxis and
5 patients had associated risk factors for epistaxis which are
shown in Table-1.
After the embolization, the immediate cessation of
bleed was achieved in all the 16 (100%) patients. However,
in 2 (12.5%) cases angioembolization had to be repeated; in
1 patient on the same day and in another patient after a
month. So the overall success rate was 87.5%. In majority
of the cases (56.25%), ipsilateral internal maxillary artery
(IMA) was the bleeding source and was embolized.
Distribution of the vessels occluded is shown in Table-2.
In 14 patients permanent embolizing agent, PVA was
Table-1: Causes of Epistaxis.
Cause

Patients (n)

Idiopathic
Hypertension
Trauma
Iatrogenic

11 (68.75%)
3 (18.75%)
1 (6.25%)
1 (6.25%)

Table-2: Distribution of vascular embolization.
Artery Embolized
Ipsilateral IMA
Bilateral IMA
Ipsilateral IMA and facial artery
Bilateral IMA ipsilateral facial artery
Bilateral IMA bilateral facial artery
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Cases(n)
9 (56.25%)
3 (18.75%)
2 (12.5%)
1 (6.25%)
1 (6.25%)

used while in 2 patient gelfoam was used which is a
temporary embolizing material. The average total hospital
stay was 3.9 days, and the average stay after embolization
was 1.9 ± 0.85 days. All patients were followed in ENT clinic
after a week of discharge.
No major or permanent complications were
observed. 2 (12.5%) patients developed minor
complications; 1 patient experienced facial pain for 7 days
and was treated with mild analgesics and 1 patient
developed haematoma at the site of femoral artery which
resolved spontaneously.

Discussion
Epistaxis is one of the otolaryngological emergency4
which may prove life threatening if not managed
appropriately. There may be many etiological factors
responsible for the nasal bleeding but in most of the cases
these bleeds are idiopathic. In this study 68.75% patients
had idiopathic epistaxis and only 31.25% had associated
risk factors for nasal bleed.
Majority of the nasal bleeds are managed easily
with anterior and/or posterior (AP) nasal packing.
However, the failure rate of AP packing is about 0%52%.5 The optimal treatment of nasal bleeds refractory to
the AP packing is still controversial.6 Traditionally the
standard treatment for uncontrolled nasal bleeds was the
surgical ligation of the bleeding vessels.7 In 1974,
Sokoloff 2 was the first one who introduced the
embolization technique for the treatment of epistaxis.
Then over the period of time, technology as well as the
level of experience improved in the field of interventional
radiology and embolization became one of the accepted
treatment option for epistaxis.
Our institution is among a few in the country where
this facility is available. Here the primary method to deal
with intractable epistaxis is angioembolization. We
achieved overall success rate of 87.5%, comparable to the
international literature, which ranges from 71 to 100%.8
This is also comparable with the average success rate of
trans-antral ligation of internal maxillary artery (IMA),
which is 87%.9 Reembolization was done in 2 cases. In 1
patient it was repeated on the same day, initially ipsilateral
IMA and facial artery were embolized but on 2nd attempt
contralateral IMA was also occluded, this could be a
contribution from the contralateral IMA. The second patient
in which embolization was repeated after a month had
uncontrolled hypertension and then bilateral IMA and
bilateral facial artery were embolized.
In 14 patients polyvinyle alcohol (PVA) particles
and in 2 patients gelfoam were used as an embolizing
material. The PVA particles vary in their size, from 45 to
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150 and even up to 700 micron. In our series PVA size was
between 250 to 350 micron. These particles must be
directed in antegrade fashion to the arteriolar bed and care
must be taken to avoid the reflux to the proximal arterial
branches.10
No major complications were observed. Potential
major complications in the literature are grand mal seizure,
facial palsy, blindness and cerebrovascular accident.11-13
These complications usually result from the reflux of the
particles into the internal carotid system. Minor
complications include temporofacial pain, headache, soft
tissue swelling, facial numbness, mental status changes, groin
pain and haematoma formation at the site of femoral vessels.
Vokes DE14 reported 21% rate of minor complications and
we observed only 12.5% which resolved over the period of
few days. During the study, follow up was also taken from all
the patients on phone and no one developed any
complication.
In this series, the average hospital stay was 1.9 ±
0.854 days after the embolization but Christensen NP11
reported 2.5 days average hospital stay after embolization.
Hypertension, aspirin and other anticoagulant drugs did not
influence the length of stay after the embolization in our
patients.
The treatment of epistaxis may need the
otolaryngologist to use many therapies. Nasal bleed
refractory to conservative management can be treated either
surgically or by embolization. But angioembolization may
be the treatment of choice for intractable nasal bleeding due
to high success rate without any serious complications,
short hospital stay, avoidance of general anaesthesia and
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less discomfort to the patients.
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